NEW YORK (GenomeWeb News) - Ingenuity Systems today said that the Genomics Institute of the Novartis Research Foundation has renewed and expanded a licensing agreement for its pathway analysis software.
The licensing deal grants GNF continued use of Ingenuity's Pathway Analysis software for the institute's research in RNA profiling, Ingenuity said. GNF originally licensed the software in 2003.
IPA is designed for pathway modeling and analysis in biomarker, toxicology, and pharmacogenomics research.
Financial terms of the agreement were not released.